The regulatory and scientific landscape for genotoxicity assessment is evolving rapidly. Following the publication of the European Commission's roadmap towards phasing out animal testing for chemical safety assessments in June 2026, stakeholders across industry, academia and regulatory authorities are exploring how innovative approaches can be integrated into future safety assessments.

What advances are being made in NAMs, mechanistic assessment and quantitative risk evaluation? And what could these developments mean for regulatory decision-making in the years ahead?

Join us at the

🎓 4th International Akademie Fresenius Online Conference
Genotoxic Compounds

📅 20-21 January 2027 | Online | Lunch-to-Lunch

🎤 Co-Chairs
✅ Krista Meurer (BASF)
✅ Carsten Kneuer (German BfR)

🎙 Hear perspectives from leading experts, including:
✅ Raffaella Corvi (European Commission JRC)
✅ Nathalie Delrue (OECD)
✅ Juan Manuel Parra Morte (EFSA)
✅ Paul White (Health Canada)
✅ Birgit Mertens (Sciensano)
✅ Cecilia Bossa (Italian National Institute of Health ISS)
✅ Carole Yauk (University of Ottawa)
✅ Stefan Pfuhler (Procter & Gamble)
✅ Carol Beevers (Corteva Agriscience)
✅ Hind Vandecasteele (L'Oréal)
✅ Melanie Bothe, PhD, DABT (Fresenius Kabi Deutschland)

🎯 Takeaways
• Latest regulatory and scientific developments in genotoxicity assessment
• Practical perspectives on NAMs, in silico tools and integrated approaches
• Future trends in risk and hazard assessment

Highlights
• EU Roadmap implementation
• NAMs and non-animal testing strategies
• PARC and OECD activities
• Quantitative assessment approaches
• (Q)SAR and data integration

ORGANIZER

Fresenius Akademie

LOCATION

Online

LINK TO EVENT

More info

Join scientists from pharmaceutical, biotechnology and academic organisations for the CN Bio e-Symposium 2026: From insight to decision, taking place virtually on 2 and 8 December 2026. The programme will explore how organ-on-a-chip and other human-relevant models are being applied to improve decision-making across research and development, with sessions covering disease modelling, ADME/DMPK, mechanistic toxicology and practical implementation.

ORGANIZER

CN Bio

LOCATION

online

LINK TO EVENT

Register here

Hosted by the Organisation for Economic Co-operation and Development (OECD), this forum will bring together regulators, scientists, policy analysts and other stakeholders to discuss how innovative approaches, including NAMs, can support chemical safety decision-making.

Discussions will focus on bridging the gap between scientific innovation and regulatory practice, including the information needed by decision-makers, opportunities to maintain high levels of protection while improving efficiency, and how chemical management frameworks may evolve to facilitate the uptake of innovative methods. In-person registration closes Tuesday 17 November.

ORGANIZER

Organisation for Economic Co-operation and Development (OECD)

LOCATION

Paris, France and online

LINK TO EVENT

Find out more and register here

The role of the microbiome in human and animal health is one of the most rapidly advancing areas within life sciences, with growing relevance for food and feed safety risk assessment. Microbiome-related considerations are already emerging in current safety assessments for example in the areas of pesticides, novel foods or food and feed additives, and regulatory applications directly involving complex microbial community products are expected in the near future. Despite these developments, the methodological tools, evidence standards and regulatory science frameworks needed to systematically incorporate microbiome data into the risk assessment remain scarse and difficult to implement. Existing guidance was not developed with microbiome endpoints in mind, and risk assessors currently lack the methods and data that would enable to address microbiome-related questions consistently and robustly.

EFSA and the broader regulatory science community have made significant investments in mapping these gaps and have collectively documented where the science is insufficient for regulatory purposes. The 2026 Scientific Colloquium on Microbiomes builds on this foundation, starting from the documented gaps and exploring what actions are needed to address them, in what order and by whom.

The colloquium addresses two domains where microbiome-related regulatory science challenges are most pressing within food and feed domains. The first is the assessment of chemicals such as pesticides, food and feed additives, and contaminants where the gut microbiome may both be a target of chemical-induced effects with consequences for host health and may also play a role in modulating chemical exposure through biotransformation. The second is the safety assessment of biological and microbiome-based products such as complex microbial feed additives and next-generation probiotic products, where the product itself intentionally aims to modulate the host microbiome and where current assessment frameworks may be insufficient. Both domains are addressed from a human and animal health perspective. The environmental microbiome such as soil, aquatic and other environmental microbial communities, is not addressed in this colloquium. EFSA intends to address environmental microbiome assessments in a subsequent dedicated initiative.

The colloquium is co-organised by EFSA and INRAE, with the French organisation also co-coordinating the World Microbiome Partnership, reflecting the importance of international collaboration in advancing microbiome regulatory science.

The overarching objective of the colloquium is to assess the maturity of available microbiome science relative to regulatory risk assessment needs, and to define what actions are required to bridge the gap between existing scientific knowledge and its use in food and feed safety risk assessments.

The colloquium is designed to produce three specific outputs:

  • Output 1 — A structured maturity assessment for each domain addressed, distinguishing what is approaching sufficient regulatory science readiness, what requires further development and tailoring for risk assessment integration, and what requires longer-term research investment.
  • Output 2 — A set of priority regulatory science actions, structured around three specific questions: what adversity criteria and evidence standards are needed before microbiome endpoints can be incorporated into regulatory decisions; what methods, data and reporting standards must be established for regulatory submissions involving microbiome data; and whether and how existing regulatory tools can be adapted to integrate microbiome-related endpoints.
  • Output 3 — A gap-closing action plan identifying who does what and when, distinguishing what falls within EFSA's and partners' direct regulatory science remit, what requires international coordination, and what requires longer-term research investment that regulatory science organisations should advocate for.

Following the opening plenary session where introductory presentations will be shared, participants will break into four parallel discussion groups addressing specific domains:

Break-out Group 1 | Chemicals and the Microbiome — Human Health Risk Assessment

Break-out Group 2 | Chemicals and the Microbiome — Animal Health Risk Assessment

Break-out Group 3 | Biological and Microbiome Products — Human Health Risk Assessment

Break-out Group 4 | Biological and Microbiome Products — Animal Health Risk Assessment

The outcome of the discussion groups will be presented in a final plenary moderated panel discussion on Day 2, designed to formulate the conclusions of the event. EFSA will issue a short report collecting and summarising the discussions following the event which will be published together with the presentations shared at the event.

The event is intended for scientists, regulatory experts and other stakeholders with expertise at the interface of microbiome science and risk assessment Participation is limited to a maximum of 120 participants, including speakers and other experts already identified by EFSA and co-organisers. Given the colloquium's focus on producing actionable regulatory science outputs, participation is specifically sought from experts who combine scientific knowledge of microbiomes with experience or familiarity of risk assessment processes. Academic researchers with strong connections to regulatory science questions are also welcome. Representatives of national competent authorities, international organisations, research institutions and industry are all encouraged to apply. A selection process will ensure sufficient representation of relevant fields of expertise, stakeholder groups and geographical balance.

The registration form can be found at link

Please note that registration may close once the maximum number of participants is reached or, at the latest, by 14 September 2026 at 12.00 CEST. After closure of registration, applicants will be informed whether they have been selected for participation.

The event will be held in person in Brussels, Belgium on 23-24 November 2026 (Day 1: 09:00–18:00 CET; Day 2: 09:00–13:00 CET). English will be the language of the event, and no interpretation will be provided.

Online participation is not foreseen — please register for this event only if you are able to attend in person.

There is no fee for participation, however participants are responsible for covering their own expenses related to travel and accommodation. Further organisational details will be communicated to selected participants.

Do not hesitate to contact the organising committee at scientific.colloquia@efsa.europa.eu for more information.

Draft Programme

ORGANIZER

EFSA

LOCATION

Brussels, Belgium

LINK TO EVENT

More info

Thursday 12 November, 9.00 – 10.00 (EST)/14.00 – 15.00 (GMT)

In this joint webinar hosted by the Health and Environmental Sciences Institute (HESI) and the NC3Rs, a team from ESQlabs will present their progress developing computational modelling approaches to predict toxicological outcomes and reduce reliance on the use of dogs, funded by the NC3Rs Virtual Second Species CRACK IT Challenge. The webinar will provide an overview of recent scientific advances, key findings, ongoing challenges and next steps in the project, with a focus on the potential application of these approaches to support improved safety assessments.

ORGANIZER

Health and Environmental Sciences Institute (HESI) and the NC3Rs

LOCATION

online

LINK TO EVENT

Register here

Öffentliche Veranstaltung mit der Möglichkeit, Fragen an die Experten*innen zu stellen

Plastik enthält Zusatzstoffe, die sich während der Nutzung aus Produkten wie beispielsweise Spielzeug, Funktionskleidung oder Lebensmittelverpackungen lösen können. Dadurch gelangen sie in die Umwelt und in den menschlichen Körper.

Erfahren Sie, was die aktuelle Wissenschaft zu Exposition und potenziellen Gefahren sagt und stellen Sie Ihre Fragen direkt an die Experten*innen:

  • Dr. Jane Muncke, Food Packaging Forum
  • Stephanie Eitner, Empa / ETH Zürich
  • Dr. Elias Zimmermann, Empa

Der Eintritt ist frei. Es wird um eine Anmeldung gebeten. 

ORGANIZER

SCAHT

LOCATION

Alte Universität, Rheinsprung 9-11, 4051 Basel

LINK TO EVENT

Anmeldung

The Swiss Centre for Applied Human Toxicology (SCAHT) is organising a hands-on ToxMCP workshop on 6 November 2026 in Basel, led by Ivo Djidrovski (in4R.ai, Utrecht University).

Participants will learn how an AI assistant can connect to public toxicology sources through ToxMCP, and gather, organise and review evidence in a guided case study, while learning to recognise the limits of AI supported outputs and where expert judgement remains essential.

Date: 6 November 2026, 09:00–12:00

Format: In person, Kollegienhaus, Petersgraben 50, 4051 Basel

Lead: Ivo Djidrovski (in4R.ai, Utrecht University)

Audience: Toxicologists, risk assessors, regulatory scientists, computational scientists and students. No programming/AI experience required.

Capacity: Limited to 30 participants, advance registration required.

Participants will need their own laptop with admin rights, a desktop version of a large language model with an active paid subscription, and a free US EPA CTX API key ( to be requested in advance). A limited number of one month subscriptions might be available for students who cannot cover the cost themselves.

Registration link

Final Program (version from October 7th, 2026)

ORGANIZER

SCAHT

LOCATION

Kollegienhaus, Petersgraben 50, 4051 Basel

LINK TO EVENT

Registration Link

4 November, 15.30 (GMT), online

Alcyomics is bringing together scientists, industry experts and innovators for a new webinar series exploring how advanced in vitro models and NAMs are helping researchers better understand efficacy, safety and immune-mediated responses earlier in development.

This session will explore how advanced human immune models can support the safety evaluation of gene and cell therapies.

ORGANIZER

Alcyomics

LINK TO EVENT

Sign up here

Tuesday 3 November, 10.30 – 13.00 (GMT)

Delivered by regulatory specialists from Health and Safety Executive (HSE), this event will explore how to address toxicology information requirements for biocidal products without the use of vertebrate testing.

The session is aimed at technical and regulatory professionals involved in the preparation and submission of data into the GB biocidal product authorisation process. Talks will explore how submissions are assessed by the GB regulator and opportunities to submit data from NAMs to assure human safety, replacing some tests involving rats, mice and rabbits.

ORGANIZER

Health and Safety Executive (HSE)

LINK TO EVENT

Register here

La validation est le plus grand obstacle pour que les New Approach Methodologies (NAM) deviennent de véritables outils dans l'évaluation des risques — ce n'est pas leur développement qui pose problème, mais la preuve qu'elles fonctionnent suffisamment bien pour être fiables et utilisées.

Le 20 octobre, le Swiss 3R Competence Center réunit à Berne des chercheurs, des représentants de l'industrie, des autorités de régulation et des décideurs politiques pour examiner directement ce parcours : des premiers fondements scientifiques jusqu'à l'acceptation réglementaire, à travers des études de cas concrètes de NAM à différents stades de validation.

ORGANIZER

Swiss 3R Competence Center et SCAHT

LOCATION

Kongresszentrum Kreuz, Berne

LINK TO EVENT

Inscrivez-vous ici :